Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

Bullboard (NDAQ:MNMD)

View:
Post by Bigmoneytalkson Mar 27, 2024 4:32pm

3 Month Predictions

Not a lot of chatter on the forum... It has been a nice jump in SP the last 3 weeks and holding at current prices. What are some predictions on SP the next 3 months?
Post by mikesrighton Mar 21, 2024 3:36pm

Musk endorses Ketamine use

Mmed is the cream de La crme of psychedelics. Not selling until at least $20  But I think I.m going to be taking a full position in Phrm which is nearing word from fda on Ketamine production ...more  
Post by whytestockson Mar 08, 2024 1:45pm

MindMeds Systematic Biotech Approach With New FDA Therapy De

JUST IN: $MNMD MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds | BenzingaShortly following the news on FDA@s " ...more  
Post by BryceCanadaon Mar 07, 2024 6:57pm

Thoughts on CYBN vs MNMD?

https://youtu.be/uW0vvAkSo18?si=efXVdd8f0bVqOrFV
Post by whytestockson Mar 07, 2024 10:45am

What's Going On With MindMed Stock Thursday? | Benzinga

Breaking News: $MNMD What's Going On With MindMed Stock Thursday? | BenzingaMind Medicine Inc (NASDAQ:MNMD) shares are trading higher Thursday after the company received FDA breakthrough therapy ...more  
Post by brownbearon Aug 14, 2023 7:42am

MindMed Secures $50.0 Million Credit Facility with K2 Health

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health ...more  
Post by StockJunkie4994on Jun 28, 2023 1:10pm

Breaking

https://thedalesreport.com/psychedelics/maps-ppc-coo-provides-roadmap-for-psychedelic-therapy-pathway-into-the-mainstream/
Post by brownbearon Jun 10, 2023 11:39am

Quiet Board

This board has been quiet for sme time, anyone have any thoughts on were this is all going.  Thanks 
Post by GajjarDron Oct 10, 2022 6:58pm

RE:RE Quiet Over Here. New Member needs Advice...

I am holder too Silo Wellness. Not to be confused with Silo Pharma which is also in same industry. Considering Silo already did a share split roll back months ago would be best "value play". ...more  
Comment by GajjarDron Oct 10, 2022 6:54pm

RE:Quiet Over Here. New Member needs Advice...

I am holder too Silo Wellness. Not to be confused with Silo Pharma which is also in same industry. Considering Silo already did a share split roll back months ago would be best "value play". ...more  
Comment by 2pacFanon Oct 10, 2022 3:36pm

RE:Quiet Over Here. New Member needs Advice...

Yes, agreed Silo Wellness been watching now since it hit .025. Buying in today after MMED cash out.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities